Chugai have received a number of reports relating to an ongoing phishing attack.
Please do not respond to any communication from Donald Grimley, or any other individual, stating to be the National Sales Manager.  For further information from Chugai relating to Phishing attacks please
click here


Welcome to Chugai Pharma UK Ltd

A warm welcome to the Chugai Pharma UK website.

Chugai is the number 1 Japanese bio-pharmaceutical company, founded in Tokyo in 1925, with a large global presence. We have approximately 6,800 employees with ¥73 billion capital and a revenue of ¥424 million.

Our first UK offices were opened in 1993 in Chiswick, West London. Our mission is to provide innovative medical products and services for the benefit of the UK and Republic of Ireland medical community and the patients in its care.

We are proud that we take personal ownership of our business by continuously striving to deliver the best solutions. We treat and value each other as equals and we are a team of individuals focused on a strong future.

We look for win-win solutions in all our business relationships which in essence makes things happen.

We hope you find this website useful and look forward to working with you in the future.

 

Transparency Declaration on 2015 Spend on Patient Organisations 
(CPUK/NPR/0471 Date of Prep: April 2016)

Antepsin™ (sucralfate) 1g/5ml Oral Suspension and Antepsin™ (sucralfate) 1g Tablets Supply Shortage – Statement of Restricted Use 11th January 2016 (UK only)

(CPUK/ANT/0027)

Antepsin™ (sucralfate) 1g/5ml Oral Suspension and Antepsin™ (sucralfate) 1g Tablets Supply Shortage – Statement of Restricted Use 11th January 2016 (Ireland only)
(CIRE/ANT/0016)

Chugai Human Rights Statement - June 2016
(CPUK/NPR/0527) 

Adverse events should be reported. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard.
Adverse events should also be reported to Chugai Pharma UK Ltd., on pv@chugai-pharm.co.uk.